drugset / Trial / NCT03347786

Verapamil for Neuroprotection in Stroke

NCT03347786

Phase 1/2 Recruiting 60 enrolled Global Neurosciences Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this research study is to test an experimental procedure called intra-arterial delivery of verapamil in patients diagnosed with acute ischemic stroke. This study investigates the safety of intra-arterial delivery of verapamil, a drug used to treat vasospasm (spasm of a blood vessel), and how it affects recovery from stroke. Recruitment is limited to patients that have received mechanical thrombectomy as standard of care.

Timeline

Start
2017-04-20
Primary completion
2026-08
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Verapamil Other / unclassified 10 mg
Subject Verapamil Other / unclassified 20 mg

Indications